Poolbeg Pharma Share Discussion Threads

[peterrr3] 19/4/2024 14:33

Each to their own, I tend to look at the fundamentals and management history as they will always follow the same path if it worked before. There is a phase 2 oral being recruited by the opposition with 4 1/2 year time line. This will be dutifully ignored, which is what I like about Poolbeg management.

[muchodinero] 19/4/2024 11:58

Peterrrrr...how is your pal Maryb the ramping nun getting on with VANQ? Oh dear..

[peterrr3] 19/4/2024 11:16

Baby biotech can only really move on hype before phase 2 done, nothing special here.

[peterrr3] 19/4/2024 10:36

Accounts are going to have little bearing I reckon as any pipeline progress is going to be flagged in an RNS up front. I saw some update on one of the patent applications a few days ago on Wipo but it looked like a standard 3rd party review request , so nothing special.

[baldrick1] 19/4/2024 10:31

There is money to be made on shares with zero revenue and only on hypes..weird markets .:))

[eeza] 19/4/2024 10:29

Need to upgrade from Abacus.

[1gw] 19/4/2024 10:05

Remarkably quiet here, given the chart. Apparently delayed results not weighing on the price at the moment.

[pgaffney] 18/4/2024 10:48

And a mountain of debt

[blackhorse23] 18/4/2024 10:25

AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders-DIVIDEND +5% -PORTFOLIO BROADENED THROUGH ACQUISITION

[inaminute] 15/4/2024 12:49

It is one of their top priorities for this year

[burtond1] 15/4/2024 10:37

Great this for #POLB Very positive to see the approval of multiple CAR T cell therapies for earlier treatment of multiple myelomaAs an oral preventative therapy for CRS #POLB 001 has the potential to enable broader, safer delivery of cancer immunotherapies to cancer patientshttps://x.com/PoolbegPharma/status/1779751510999752894

[chica1] 12/4/2024 14:45

How do u come to that conclusion?
No point in going to the Nasdaq unless you're very very well capitalised.
I'd say a Phase 2 Clinical trial will be necessary expecially since cytokine storm can effect multiple organs

[inaminute] 12/4/2024 14:00

This will be on Nasdaq by year end

[anderson3] 12/4/2024 11:26

Has CF new venture been ipo’d

[peterrr3] 12/4/2024 10:29

Thanks an interesting read, especially as many quite some way from commercialisation on entry.

[chica1] 11/4/2024 10:15

Was reading this last night
Lots of deals in the Bio--Pharma sectors.
There's a decent amount of reverse mergers onto the Nasdaq with private placements.
Interesting!

www.biospace.com/article/biospace-mergers-and-acquisitions-tracker/

[peterrr3] 10/4/2024 19:09

I am optimistic for at least a pump as the grant strike price needs to hold a 70% increase for a couple of weeks or the team won't be happy. I also don't see why they need execs like a full time in house corporate lawyer no matter how good, especially when the IP work is outsourced anyway.I was hoping for the application for an orphan to show fast track and less onerous trial requirements from the Fda along with longer protection but I don't see anything new on Wipo which could flag this.

[chica1] 10/4/2024 11:29

Nope wasn't referring to CF.
POLB001 came out of the Hvivo incubator so that was well before they were acquired.
And the 2 heavy hitters at Amryt that got the original Lojuxta Aergerion deal done were Joe Wiley and Rory Nealon.Im sure the new Ex Amryt hires are all good people but the jury is still out on the strategy.
Making a 360 degree turn from a candidate for severe flu into Oncology is a big move.
Then again lots of drugs have been recalibrated to treat different conditions.2 off the top of my head Botox and Viagra.

[klosters65] 10/4/2024 11:05

I assume you are referring to CF. Without him, you would have no Company. His ability to persuade top class people to to join and manage the company is exemplary.

[eeza] 10/4/2024 10:31

Maybe need to spend some time to see if they can find the Finals.


As soon as 'Mouth of Ireland' turns up you can expect chaos.

[chica1] 10/4/2024 09:31

Cash on hand will be interesting here.
There's alot more pigs at the trough to feed with the new hires.
At this stage I would have thought the hiring of more scientists (who are generally cheap and frugal)would be more beneficial to Poolbeg than an expensive sales and marketing team.
They'll definitely be needing big Pharma help by year end.

[lfdkmp] 10/4/2024 06:46

A senior moment Hotteruk6?

I know them only too well :-)

[hotteruk6] 09/4/2024 19:44

oops wrong board